A business in context
LLY research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-15 | Alvarez Ralph | A · Grant / award | Common Stock | 10.99 | 1129.35 |
| 2026-06-15 | Sulzberger Gabrielle | A · Grant / award | Common Stock | 4.39 | 1129.35 |
| 2026-06-15 | LUCIANO JUAN R | A · Grant / award | Common Stock | 14.09 | 1129.35 |
| 2026-06-15 | Fyrwald J Erik | A · Grant / award | Common Stock | 8.78 | 1129.35 |
| 2026-06-10 | Yuffa Ilya | S · Sale | Common Stock | 2500.0 | 1150.77 |
| 2026-05-18 | Alvarez Ralph | A · Grant / award | Common Stock | 12.57 | 988.09 |
| 2026-05-18 | Sulzberger Gabrielle | A · Grant / award | Common Stock | 5.02 | 988.09 |
| 2026-05-18 | LUCIANO JUAN R | A · Grant / award | Common Stock | 16.11 | 988.09 |
| 2026-05-18 | Fyrwald J Erik | A · Grant / award | Common Stock | 10.04 | 988.09 |
| 2026-05-06 | LILLY ENDOWMENT INC | S · Sale | Common Stock | 2208.0 | 996.18 |
| 2026-05-06 | LILLY ENDOWMENT INC | S · Sale | Common Stock | 13620.0 | 995.23 |
| 2026-04-20 | Sulzberger Gabrielle | A · Grant / award | Common Stock | 5.39 | 919.9 |
| 2026-04-20 | LUCIANO JUAN R | A · Grant / award | Common Stock | 17.3 | 919.9 |
| 2026-04-20 | Fyrwald J Erik | A · Grant / award | Common Stock | 10.78 | 919.9 |
| 2026-04-20 | Alvarez Ralph | A · Grant / award | Common Stock | 13.5 | 919.9 |
Identity & relationships
SEC issuer · 0000059478ELI LILLY & Co
Eli Lilly (United Kingdom)Eli Lilly (Canada)Eli Lilly (Germany)Eli Lilly (Singapore)Eli Lilly (India)Lilly (China)Eli LillyLilly France
- Legal Entity Identifier
- FRDRIPF3EKNDJ2CQJL29
- GLEIF legal name
- ELI LILLY AND COMPANY
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-05-15T05:29:22Z
Search names and former names
View Wikidata identity and references ↗
- Eli Lilly and Company · alias · wikidata
- Eli Lily · alias · wikidata
- Lilly · alias · wikidata
- Eli Lilly (United Kingdom) · subsidiary · wikidata
- Eli Lilly (Canada) · subsidiary · wikidata
- Eli Lilly Canada Inc. · subsidiary · wikidata
- Eli Lilly (Germany) · subsidiary · wikidata
- Eli Lilly (Singapore) · subsidiary · wikidata
- Eli Lilly (India) · subsidiary · wikidata
- Eli Lilly and Company (India) Pvt. Ltd. · subsidiary · wikidata
- Lilly (China) · subsidiary · wikidata
- Eli Lilly · subsidiary · wikidata
- Lilly France · subsidiary · wikidata
- LILLY ELI & CO · former SEC name · 1994-10-26 to 2019-10-25
- LILLY ELI & CO ET AL · former SEC name · 1994-07-27 to 1994-10-14
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $45.04B | $47.95B |
| 2023-12-31 | $34.12B | $37.39B |
| 2022-12-31 | $28.54B | $32.56B |
| 2021-12-31 | $28.32B | $34.89B |
| 2020-12-31 | $24.54B | $31.66B |
| 2019-12-31 | $22.32B | $29.15B |
| 2018-12-31 | $21.49B | $28.58B |
| 2017-12-31 | $19.97B | $27.21B |